Multiple Sclerosis Global Clinical Trials Review, H1, 2018

  • ID: 4530842
  • Clinical Trials
  • Region: Global
  • 940 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Biogen Inc
  • E. Merck KG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Novartis AG
  • MORE
Multiple Sclerosis Global Clinical Trials Review, H1, 2018

Summary

The clinical trial report, “Multiple Sclerosis Global Clinical Trials Review, H1, 2018" provides an overview of Multiple Sclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple Sclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Biogen Inc
  • E. Merck KG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Novartis AG
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Multiple Sclerosis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Multiple Sclerosis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Multiple Sclerosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Multiple Sclerosis
  • Feb 21, 2018: Oryzon to present at upcoming international conferences
  • Feb 02, 2018: Clene Nanomedicine Announces Preclinical Results of A Novel Gold Nanocrystal Remyelinating Treatment for Multiple Sclerosis at ACTRIMS Forum Annual Meeting
  • Feb 01, 2018: Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal
  • Jan 31, 2018: MediciNova Announces Presentation of the SPRINT-MS Phase 2b Study of MN-166 (ibudilast) in Progressive MS at the ACTRIMS Forum
  • Jan 29, 2018: ORYZON announces First Patient In in ORY-2001 MS Phase IIA trial SATEEN and presents new data on ORY-2001 at the third annual ACTRIMS Forum 2018 in San Diego
  • Jan 23, 2018: ORYZON to present at two US investor conferences
  • Jan 12, 2018: QIMR Berghofer-developed Immunotherapy for Multiple Sclerosis gets Green Light From US FDA to Proceed with Patient Enrollment at US sites for Global Phase 1 Clinical Study
  • Dec 18, 2017: Mabion with a new innovative indication in the treatment of multiple sclerosis for MabionCD20
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About
  • Contact
  • Source
List of Tables
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials by Region, 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, North America, Top Countries, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
  • Proportion of Multiple Sclerosis to Central Nervous System Clinical Trials, G7 Countries (%), 2018*
  • Multiple Sclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Multiple Sclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Multiple Sclerosis to Central Nervous System Clinical Trials, E7 Countries (%), 2018*
  • Multiple Sclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Multiple Sclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials by Phase, 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Multiple Sclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
List of Figures
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials by Region (%), 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
  • Proportion of Multiple Sclerosis to Central Nervous System Clinical Trials, G7 Countries (%), 2018*
  • Multiple Sclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Multiple Sclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Multiple Sclerosis to Central Nervous System Clinical Trials, E7 Countries (%), 2018*
  • Multiple Sclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Multiple Sclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
  • Multiple Sclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Multiple Sclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Multiple Sclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Biogen Inc
  • Novartis AG
  • Sanofi
  • E. Merck KG
  • Teva Pharmaceutical Industries Ltd
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Perrigo Company Plc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll